Globotriaosylceramide-induced reduction of KCa1.1 channel activity and activation of the Notch1 signaling pathway in skin fibroblasts of male Fabry patients with pain-Reference-Cited by-同舟云学术

Globotriaosylceramide-induced reduction of KCa1.1 channel activity and activation of the Notch1 signaling pathway in skin fibroblasts of male Fabry patients with pain

Published:2020-02 Issue: Volume:324 Page:113134
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Rickert Vanessa,Kramer Daniela,Schubert Anna-Lena,Sommer Claudia,Wischmeyer Erhard,Üçeyler Nurcan^ORCID

Funder

German Research Foundation

Deutsche Forschungsgemeinschaft

University of Würzburg

DFG

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference48 articles.

1. Image processing with ImageJ;Abràmoff;Biophoton. Int.,2004

2. Characterization of classical and nonclassical Fabry disease: a multicenter study;Arends;J. Am. Soc. Nephrol.,2017

3. Ca2+−activated K+ channels: from protein complexes to function;Berkefeld;Physiol. Rev.,2010

4. Hypoxia augments cytokine (transforming growth factor-beta (TGF-β) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts;Berse;Clin. Exp. Immunol.,1999

5. Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy;Biancini;Biochim. Biophys. Acta,2012

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inflammatory cytokine expression in Fabry disease: impact of disease phenotype and alterations under enzyme replacement therapy;Frontiers in Immunology;2024-08-21

2. Expanding the Neurological Phenotype of Anderson–Fabry Disease: Proof of Concept for an Extrapyramidal Neurodegenerative Pattern and Comparison with Monogenic Vascular Parkinsonism;Cells;2024-06-29

3. Elevated interleukin-8 expression by skin fibroblasts as a potential contributor to pain in women with Fabry disease;PLOS ONE;2024-04-09

4. Dysregulation of sphingolipid metabolism in pain;Frontiers in Pharmacology;2024-03-08

5. Characterizing pain in patients with Fabry disease: Findings from a web-based cross-sectional survey in the US;2024-01-05